Endometrial Cancer Clinical Trials
Endometrial Cancer clinical trials evaluate new drugs, immunotherapies, radiation approaches, and combination treatments for endometrial Cancer. Corterve aggregates actively recruiting Endometrial Cancer studies from the public ClinicalTrials.gov registry so you can browse them by location and eligibility. Many oncology trials enroll patients at different stages of disease, including newly diagnosed and previously treated. This is general information, not medical advice — review any study with your oncology care team before enrolling.
Recruiting Endometrial Cancer studies
- A Study of ART0380 for the Treatment of Advanced or Metastatic Solid TumorsNCT04657068PHASE1, PHASE2Artios Pharma LtdBirmingham, Alabama
- Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial CancerNCT07022483PHASE3Daiichi SankyoFort Lauderdale, Florida
- Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)NCT07044336PHASE3AstraZenecaTucson, Arizona
- Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid TumorsNCT06218914PHASE1AstraZenecaDuarte, California
- A Phase 1 Study of the Safety and Tolerability of CTX-10726NCT07419841PHASE1Compass TherapeuticsOmaha, Nebraska
- The DETECT Study: Discovery and Evaluation of Testing for Endometrial and Ovarian Cancer in TamponsNCT03538665University of Alabama at BirminghamBirmingham, Alabama
- A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)NCT06952504PHASE3Merck Sharp & Dohme LLCMobile, Alabama
- Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid TumorsNCT06974110PHASE1MOMA TherapeuticsPhoenix, Arizona
- Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid TumorsNCT05797168PHASE1, PHASE2AstraZenecaDuarte, California
- A Study of PF-08046054/SGN-PDL1V in Advanced Solid TumorsNCT05208762PHASE1Seagen, a wholly owned subsidiary of PfizerBirmingham, Alabama
- DESTINY-PANTUMOUR04NCT07124000AstraZenecaBirmingham, Alabama
- Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) CancersNCT03564340PHASE1, PHASE2Regeneron PharmaceuticalsBirmingham, Alabama
Endometrial Cancer trials by state
Endometrial Cancer trials by metro
Frequently asked questions
- How do I find recruiting Endometrial Cancer clinical trials?
- Corterve aggregates actively recruiting Endometrial Cancer studies from the public ClinicalTrials.gov registry. Browse the studies listed on this page or take a free health assessment to see trials you may qualify for based on your profile.
- Are Endometrial Cancer clinical trials free to join?
- Study participation is typically free — research sponsors cover the cost of the investigational treatment and study-related visits. Many trials also compensate participants for time and travel. Details vary by study.
- Who can take part in a Endometrial Cancer clinical trial?
- Each study has its own eligibility criteria (for example age, disease stage, and prior treatments). This page is general information and not medical advice; discuss any specific trial with your healthcare provider to confirm whether it is appropriate for you.